Quality of primary care among individuals receiving treatment for opioid use disorder
Spithoff S, Kiran T, Khuu W, Kahan M, Guan Q, Tadrous M, Leece P, Martins D, Gomes T. Can Fam Physician. 2019; 65(5):343-51. Epub 2019 May 1.
Publications
Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada
Martins D, Khuu W, Tadrous M, Juurlink DN, Mamdani MM, Paterson JM, Gomes T. Pharmacoepidemiol Drug Saf. 2019; 28(5):726-33. Epub 2019 Mar 14.
Evaluation of the fentanyl patch-for-patch program in Ontario, Canada
Tadrous M, Greaves S, Martins D, Nadeem K, Singh S, Mamdani MM, Juurlink DN, Gomes T. Int J Drug Policy. 2019; 66:82-6. Epub 2019 Feb 8.
Contributions of prescribed and non-prescribed opioids to opioid-related deaths: a population-based cohort study in Ontario, Canada
Gomes T, Khuu W, Martins D, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. BMJ. 2018; 362:k3207. Epub 2018 Aug 29.
Trends in the utilisation of COPD therapeutic regimens before and after the introduction of LAMA/LABA combination products: a population-based study
Parkin L, Khuu W, Stanbrook MB, Tadrous M, Martins D, Gomes T. Respir Med. 2018; 143:1-7. Epub 2018 Aug 14.
Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: a multi-jurisdictional cross-sectional study
Gomes T, Khuu W, Craiovan D, Martins D, Hunt J, Lee K, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. Drug Alcohol Depend. 2018; 191:86-90. Epub 2018 Jul 31.
Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: a population-based retrospective cohort study
Verma AA, Khuu W, Tadrous M, Gomes T, Mamdani MM. PLoS Med. 2018; 15(6):e1002584. Epub 2018 Jun 11.
Evaluating the early impacts of delisting high-strength opioids on patterns of prescribing in Ontario
Guan Q, Khuu W, Martins D, Tadrous M, Chiu M, Do MT, Gomes T. Health Promot Chronic Dis Prev Can. 2018; 38(6):256-62. Epub 2018 Jun 1.
The burden of opioid-related mortality in the United States
Gomes T, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. JAMA Network Open. 2018; 1(2):e180217. Epub 2018 Jun 1.
A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
Antoniou T, Macdonald EM, Yao Z, Gomes T, Tadrous M, Ho JM, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network. BMC Musculoskelet Disord. 2018; 19:160. Epub 2018 May 22.